Comments
The Rupee appreciated by five paise to settle at more than two-week high of 74.11 against the US dollar on Monday tracking positive domestic equities and weak American currency.
At the interbank forex market, the domestic unit traded in a narrow range as rising COVID-19 cases offset positive sentiments surrounding the progress on the vaccine front.
AstraZeneca on Monday said that late-stage trials of its COVID-19 vaccine were “highly effective” in preventing disease.
A vaccine developed by AstraZeneca and the University of Oxford prevented 70 per cent of people from developing the coronavirus in late-stage trials.
The Rupee opened at 74.12 against the US dollar and touched a high of 74.04 and a low of 74.22 in day trade.
The Rupee finally settled at 74.11 -- the highest closing level since November 6 -- with gains of 11 paise. On Friday, the local unit had settled at 74.16 against the greenback.
“Rupee traded in a range after opening strong on the back of a weak dollar index. The tight range of 74.00-74.45 remains, on back of awaited stimulus deals from the US. Crude prices scaling high give some support to USDINR as it keeps holding 74.00,” said Jateen Trivedi, Senior Research Analyst (Commodity & Currency) at LKP Securities.
The dollar index, which gauges the greenback’s strength against a basket of six currencies, was down 0.23 per cent to 92.17.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.